News Conference News THT 2024 Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients Michael O'Riordan March 07, 2024
News Conference News THT 2024 Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS Michael O'Riordan March 06, 2024
Presentation THT 2024 Impact Of Rapid Up-Titration of Guideline-Directed Medical Therapies On Quality of Life: Insights From The STRONG-HF Trial Presenter: Kamile Cerlinskaite-Bajore March 06, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
Presentation THT 2024 Participant-Centric, Digital, and Decentralized: What Are the Innovations We Need in How We Do Research? Presenter: Harlan Krumholz March 04, 2024
Presentation THT 2024 Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial Presenter: JoAnn Lindenfeld March 04, 2024